David Z.I. Cherney
- Endocrinology, Diabetes and Metabolism top 0.02%
- Diabetes Treatment and Management 181
- Diabetes Management and Research 80
- Hormonal Regulation and Hypertension 27
- Nephrology top 0.05%
- Chronic Kidney Disease and Diabetes 82
- Dialysis and Renal Disease Management 29
-
- Blood Pressure and Hypertension Studies 43
- Surgery top 0.2%
- Pancreatic function and diabetes 81
- Pharmacology top 0.5%
-
- Metabolism, Diabetes, and Cancer 41
- Co-authors
- Bruce A. PerkinsHiddo J.L. HeerspinkYuliya LytvynPetter BjornstadVesta LaiMaximilian von EynattenChristopher P. CannonMansoor Husain
- Partner nations
- CanadaUnited StatesNetherlands
In The Last Decade
David Z.I. Cherney
314 papers receiving 14.6k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Endocrinology, Diabetes and Metabolism 10.7k
- Nephrology 3.8k
- Cardiology and Cardiovascular Medicine 2.9k
- Surgery 4.9k
- Pharmacology 1.5k
Countries citing papers authored by David Z.I. Cherney
This map shows the geographic impact of David Z.I. Cherney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Z.I. Cherney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Z.I. Cherney more than expected).
Fields of papers citing papers by David Z.I. Cherney
This network shows the impact of papers produced by David Z.I. Cherney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Z.I. Cherney. The network helps show where David Z.I. Cherney may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Z.I. Cherney, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 8 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 2 | |
| 9 | 2023 | 63 | |
| 10 | 2023 | 17 | |
| 11 | 2023 | 5 | |
| 12 | 2022 | 41 | |
| 13 | 2022 | 42 | |
| 14 | 2021 | 4 | |
| 15 | 2021 | 1 | |
| 16 | 2021 | 14 | |
| 17 | Sotagliflozin in Patients with Diabetes and Chronic Kidney Diseasebreakdown → | 2020 | 789 |
| 18 | 2020 | 175 | |
| 19 | 2018 | 19 | |
| 20 | Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitusbreakdown → | 2013 | 976 |
About David Z.I. Cherney
David Z.I. Cherney is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine, having authored 331 papers that have together received 14.8k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (181 papers), Chronic Kidney Disease and Diabetes (82 papers), Pancreatic function and diabetes (81 papers), Diabetes Management and Research (80 papers), Blood Pressure and Hypertension Studies (43 papers), Metabolism, Diabetes, and Cancer (41 papers), Dialysis and Renal Disease Management (29 papers) and Hormonal Regulation and Hypertension (27 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (10.7k citations), Nephrology (3.8k citations) and Cardiology and Cardiovascular Medicine (2.9k citations). David Z.I. Cherney has collaborated with scholars based in Canada, United States and Netherlands. Frequent co-authors include Bruce A. Perkins, Hiddo J.L. Heerspink, Yuliya Lytvyn, Petter Bjornstad, Vesta Lai, Maximilian von Eynatten, Christopher P. Cannon, Mansoor Husain, Darren K. McGuire and David Fitchett. Their work appears in journals such as New England Journal of Medicine, The Lancet and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.